This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Galectin Therapeutics Inc (GALT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 29.13M 10.49M 9.36M 6.40M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 29.66M 10.69M 9.52M 6.50M
Property, Plant & Equipment, Gross 74.00K 74.00K 74.00K 321.00K
Accumulated Depreciation & Depletion 73.00K 71.00K 66.00K 315.00K
Property, Plant & Equipment, Net 1.00K 3.00K 8.00K 6.00K
Intangibles 15.00K 23.00K 30.00K 36.00K
Other Non-Current Assets 0.00 0.00 6.00K 69.00K
Total Non-Current Assets 16.00K 26.00K 44.00K 111.00K
Liabilities & Shareholder Equity
Total Assets 29.68M 10.71M 9.56M 6.61M
Accounts Payable 906.00K 762.00K 930.00K 384.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 68.00K 73.00K 557.00K 80.00K
Total Current Liabilities 1.70M 2.49M 1.64M 2.22M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 6.75M 6.76M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 6.78M 6.75M 6.76M 6.52M
Total Liabilities 8.48M 9.23M 8.40M 8.74M
Preferred Stock Equity 567.00K 7.33M 632.00K 632.00K
Common Stock Equity 20.63M -5.85M 533.00K -2.76M
Common Par 22.00K 18.00K 16.00K 13.00K
Additional Paid In Capital 139.53M 102.84M 80.54M 66.37M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -118.92M -101.96M -80.02M -69.14M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 -6.75M 0.00 0.00
Total Capitalization 21.20M 1.48M 1.16M -2.12M
Total Equity 21.20M 1.48M 1.16M -2.12M
Total Liabilities & Stock Equity 29.68M 10.71M 9.56M 6.61M
Total Common Shares Outstanding 22.28M 18.39M 16.06M 12.92M
Preferred Shares 1.40M 1.45M 1.56M 1.56M
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 21.85M 16.87M 15.13M 11.99M
Diluted Weighted Shares Outstanding 21.85M 16.87M 15.13M 11.99M
Number of Employees 7 6 5 7
Number of Part-Time Employees 0 0 0 0
GALT News

GALT Galectin Therapeutics Inc

Analysts Ratings for GALT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GALT ANALYST REPORT

Brokerage Partners

GALT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs